FDA.reportPublic FDA data

clobetasol propionate 0.05 % Ophthalmic Suspension

RxCUI
2683740
RxNorm name
clobetasol propionate 0.05 % Ophthalmic Suspension
Display name
clobetasol propionate 0.05 % Ophthalmic Suspension
Full name
clobetasol propionate 0.05 % Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BYQLOVICLOBETASOL PROPIONATEHarrow Eye, LLC31ca5a0f-812e-491d-aa00-d8ed424ba3222026-01-26Warnings, Adverse reactionsExact identifier
rxcui: 2683740
CLOBETASOL PROPIONATECLOBETASOL PROPIONATEEyenovia, Inc.7687c980-7006-4222-80b9-c32773772d3e2025-04-16Warnings, Adverse reactionsExact identifier
rxcui: 2683740

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
31ca5a0f-812e-491d-aa00-d8ed424ba322clobetasol propionate 0.05 % Ophthalmic SuspensionPSN3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126
31ca5a0f-812e-491d-aa00-d8ed424ba322clobetasol propionate 0.05 % Ophthalmic SuspensionSY3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126
31ca5a0f-812e-491d-aa00-d8ed424ba322clobetasol propionate 0.5 MG/ML Ophthalmic SuspensionSCD3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126
7687c980-7006-4222-80b9-c32773772d3eclobetasol propionate 0.05 % Ophthalmic SuspensionSY3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI, for topical ophthalmic use Initial U.S. Approval: 198520250416
7687c980-7006-4222-80b9-c32773772d3eclobetasol propionate 0.5 MG/ML Ophthalmic SuspensionSCD3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI, for topical ophthalmic use Initial U.S. Approval: 198520250416
7687c980-7006-4222-80b9-c32773772d3eclobetasol propionate 0.05 % Ophthalmic SuspensionPSN3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI, for topical ophthalmic use Initial U.S. Approval: 198520250416